[68Ga]Ga-TATE

Gallium-68 labeled trans-activating transcriptional activator (TATE) analog tracer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for [68Ga]Ga-TATE, covering 2024-02-26 to 2024-02-26. Get the full timeline:

Most recent: Clinical Trial Update: A Head-to-head Comparison of [68Ga]Ga-FAPI and [68Ga]Ga-TATE PET/CT in Patients With Nasopharyngeal Carcinoma: a Single-center, Prospective Study [Phase 1, Phase 2]

See pricing